美国 · 平台与数据 · MarketBeat

HLS Therapeutics Targets 2027 Growth With Cardiovascular Expansion and New Deals

来源：MarketBeat · 美国 1 小时前

HLS Therapeutics (TSE:HLS) outlined plans to build on its cardiovascular portfolio and pursue additional business-development opportunities as the specialty pharmaceutical company…

在 MarketBeat 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)

HLS Therapeutics Targets 2027 Growth With Cardiovascular Expansion and New Deals

推荐阅读

Australia's Q3 PPI rises 1.1% Q/Q; annual producer inflation holds steady at 3.6%

These 2 Nearly 100% Historically Accurate Market Signals Are Conflicting. Here's What Investors Should Do.

BYD shares dip as Q3 earnings disappoint

What gave this city its ‘best place to retire’ crown? You can actually afford to live there.

Sify (SIFY) Q2 2027 Earnings Call Transcript

Vigonvita Investors Extend Share Lock‑Up to Signal Long‑Term Confidence

HLS Therapeutics Targets 2027 Growth With Cardiovascular Expansion and New Deals

分享

推荐阅读

Australia's Q3 PPI rises 1.1% Q/Q; annual producer inflation holds steady at 3.6%

These 2 Nearly 100% Historically Accurate Market Signals Are Conflicting. Here's What Investors Should Do.

BYD shares dip as Q3 earnings disappoint

What gave this city its ‘best place to retire’ crown? You can actually afford to live there.

Sify (SIFY) Q2 2027 Earnings Call Transcript

Vigonvita Investors Extend Share Lock‑Up to Signal Long‑Term Confidence